Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors-Reference-Cited by-同舟云学术

Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors

Published:2005-09 Issue:5 Volume:122 Page:707-721
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Ogawa Sumito,Lozach Jean,Benner Chris,Pascual Gabriel,Tangirala Rajendra K.,Westin Stefan,Hoffmann Alexander,Subramaniam Shankar,David Michael,Rosenfeld Michael G.,Glass Christopher K.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference50 articles.

1. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function;Adachi;Immunity,1998

2. Toll-like receptor signalling;Akira;Nat. Rev. Immunol.,2004

3. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis;Auphan;Science,1995

4. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-κB and activator protein-1 repression;Bladh;Mol. Pharmacol.,2005

5. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway;Caelles;Genes Dev.,1997

Cited by 563 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxysterol binding protein regulates the resolution of TLR-induced cytokine production in macrophages;Proceedings of the National Academy of Sciences;2024-08-06

2. Significant Interaction between Melatonin and Titanium Bone Implants: Available Evidence and Future Research Directions;Current Pharmaceutical Biotechnology;2024-06-25

3. The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity;Endocrine Reviews;2024-03-29

4. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection;Pathogens;2024-02-12

5. Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity;Frontiers in Oncology;2024-01-11